D.E. Shaw & Co
LSTA icon

D.E. Shaw & Co’s Lisata Therapeutics LSTA Stock Holding History

D.E. Shaw & Co’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-91
Closed -$8K – 3465
2016
Q2 		$8K Sell
91
-243
-73% -$22.4K ﹤0.01% 3316
2016
Q1 		$37K Sell
334
-461
-58% -$45.3K ﹤0.01% 3347
2015
Q4 		$129K Buy
795
+552
+227% +$101K ﹤0.01% 3646
2015
Q3 		$54K Buy
243
+27
+13% +$6.77K ﹤0.01% 3659
2015
Q2 		$61K Sell
216
-232
-52% -$86.2K ﹤0.01% 3677
2015
Q1 		$171K Buy
448
+261
+140% +$141K ﹤0.01% 3473
2014
Q4 		$106K Buy
187
+49
+36% +$33.4K ﹤0.01% 3900
2014
Q3 		$115K Sell
138
-158
-53% -$138K ﹤0.01% 3967
2014
Q2 		$290K Sell
296
-52
-15% -$50.6K ﹤0.01% 3850
2014
Q1 		$367K Buy
+348
New +$377K ﹤0.01% 3811

Other funds holding LSTA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $2.78B AUM 26.09% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

D.E. Shaw & Co's LSTA Position: Q3 2016 in Review

D.E. Shaw & Co sold out of Lisata Therapeutics (LSTA) in Q3 2016, closing a stake of 91 shares — an estimated $8K sold.

D.E. Shaw & Co first reported a position in LSTA in Q1 2014 and held it in 10 quarters. The position peaked at $367K in Q1 2014. 28 funds tracked by Wall St. Rank hold LSTA as of Q3 2016.

  • D.E. Shaw & Co reported no remaining Lisata Therapeutics position as of Q3 2016 after selling out during the quarter.
  • D.E. Shaw & Co sold 91 Lisata Therapeutics shares in Q3 2016, an estimated $8K.
  • D.E. Shaw & Co first reported a position in Lisata Therapeutics in Q1 2014 and held it in 10 quarters.
  • D.E. Shaw & Co's Lisata Therapeutics position peaked at $367K in Q1 2014.
  • 28 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q3 2016.

Based on D.E. Shaw & Co's 13F filing for Q3 2016, filed 14 Nov 2016.